Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2

Satoshi Inoue(University of Leicester), Tak W. Mak(University Health Network), Mathieu Lupien(Ontario Institute for Cancer Research), Bryan E. Snow(University Health Network), Derrick J. Rossi(New York Stem Cell Foundation), Luisa Cimmino(Howard Hughes Medical Institute), Jillian Haight(University Health Network), Andrew Wakeham(Ontario Institute for Cancer Research), Chiara Gorrini(Princess Margaret Cancer Centre), Ross L. Levine(Memorial Sloan Kettering Cancer Center), Wanda Y. Li(Ontario Institute for Cancer Research), Isabel Beerman(Boston Children's Hospital), Rob A. Cairns(University Health Network), Aline Cristiane Planello(University Health Network), Garry P. Nolan(Stanford University), François Lemonnier(Université Paris-Est Créteil), Gerry Melino(University of Rome Tor Vergata), C. Bassi(University of Leeds), Shu Yi Shen(University Health Network), Sean C. Bendall(Stanford University), Kimberly Straley(Agios Pharmaceuticals (United States)), Dana M. Larsen, Katharine Yen(Agios Pharmaceuticals (United States)), Qinxi Li(Xiamen University), David W. Cescon(Princess Margaret Hospital), Alan Tseng(Harvard University Press), Daniel D. De Carvalho(University Health Network), Andrew Elia(Ontario Institute for Cancer Research), Kelsie L. Thu, Alan H. Shih(Tisch Hospital), Ken J. Kron(Ontario Genomics), Iannis Aifantis(New York University), Zhenyue Hao(Princess Margaret Cancer Centre), Naoya Takayama(Chiba University), Takeshi Ueda(Kindai University), Alisha R. Elford(Ontario Institute for Cancer Research), Kiichi Murakami(Ontario Institute for Cancer Research), Evan Lind(Oregon Health & Science University)
Cancer Cell
July 16, 2016
Cited by 200


Related Papers